Cargando…

Cardiovascular events and atherosclerosis in patients with type 2 diabetes and impaired glucose tolerance: What are the medical treatments to prevent cardiovascular events in such patients?

Type 2 diabetes mellitus and impaired glucose tolerance (IGT) significantly induce advanced coronary artery disease and systemic atherosclerosis. Thus, type 2 diabetes mellitus and IGT are traditional risk factors of cardiovascular disease. In contrast, acute coronary syndrome is frequently caused b...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ishii, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248425/ https://www.ncbi.nlm.nih.gov/pubmed/35377559 http://dx.doi.org/10.1111/jdi.13799

Ejemplares similares

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
por: Preiss, David, et al.
Publicado: (2012)

The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis
por: Holm Nielsen, S., et al.
Publicado: (2021)

Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: Long‐term follow‐up of the ESCAPE study
por: Sohn, Minji, et al.
Publicado: (2022)

What is the relationship between sclerostin and cardiovascular events in hemodialysis patients?
por: Zhao, Yu, et al.
Publicado: (2020)

The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events
por: Magdalena, Krintus, et al.
Publicado: (2006)

Hypoglycemia, Diabetes, and Cardiovascular Events
por: Desouza, Cyrus V., et al.
Publicado: (2010)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
por: Palanca, Ana, et al.
Publicado: (2019)

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes
por: Tai, Shi, et al.
Publicado: (2022)

Impact of Subclinical Atherosclerosis on Cardiovascular Disease Events in Individuals With Metabolic Syndrome and Diabetes: The Multi-Ethnic Study of Atherosclerosis
por: Malik, Shaista, et al.
Publicado: (2011)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Vascular Events and Carotid Atherosclerosis: A 5-Year Prospective Cohort Study in Patients with Type 2 Diabetes and a Contemporary Cardiovascular Prevention Treatment
por: Vouillarmet, Julien, et al.
Publicado: (2019)

Hospitalized cardiovascular events in patients with diabetic macular edema
por: Nguyen-Khoa, Bao-Anh, et al.
Publicado: (2012)

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
por: Wang, Le, et al.
Publicado: (2020)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Atherosclerosis profile and incidence of cardiovascular events: a population-based survey
por: Robinson, Jennifer G, et al.
Publicado: (2009)

Carotid Atherosclerosis Progression and Risk of Cardiovascular Events in a Community in Taiwan
por: Chen, Pei-Chun, et al.
Publicado: (2016)

Resistive and Pulsatile Arterial Hemodynamics and Cardiovascular Events: The Multiethnic Study of Atherosclerosis
por: Lilly, Scott M., et al.
Publicado: (2014)

Patient Selection for Pemafibrate Therapy to Prevent Adverse Cardiovascular Events
por: Izumida, Toshihide, et al.
Publicado: (2022)

Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
por: Reaven, Peter D., et al.
Publicado: (2009)

Higher blood pressure predicts diabetes and enhances long‐term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty‐three‐year follow‐up of the Daqing diabetes prevention study
por: Li, Xiaojue, et al.
Publicado: (2019)

Impaired Chronotropic Response to Exercise Stress Testing in Patients With Diabetes Predicts Future Cardiovascular Events
por: Ho, P. Michael, et al.
Publicado: (2008)

Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes
por: Johnston, Stephen S., et al.
Publicado: (2011)

Neutrophil to lymphocyte ratio is not related to carotid atherosclerosis progression and cardiovascular events in the primary prevention of cardiovascular disease: Results from the IMPROVE study
por: Mannarino, Massimo R., et al.
Publicado: (2021)

Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Arnott, Clare, et al.
Publicado: (2020)

Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
por: Pancholia, A.K.
Publicado: (2018)

Reporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan()
por: Handa, Nobuhiro, et al.
Publicado: (2015)

A review of picotamide in the reduction of cardiovascular events in diabetic patients
por: Celestini, Andrea, et al.
Publicado: (2007)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Cardiovascular Events in Patients with Thyroid Storm
por: Waqar, Zainulabedin, et al.
Publicado: (2021)

Predictors of Cardiovascular Events in Hypertensive Patients with High Cardiovascular Risk
por: Tasić, Ivan, et al.
Publicado: (2020)

Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes
por: Mita, Tomoya, et al.
Publicado: (2019)

Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery
por: Biteker, Murat, et al.
Publicado: (2011)

Atherosclerosis of the descending aorta predicts cardiovascular events: a transesophageal echocardiography study
por: Varga, Albert, et al.
Publicado: (2004)

Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes : Epidemiology and risk factors
por: Giorda, Carlo B., et al.
Publicado: (2008)

Elucidation of the Strongest Predictors of Cardiovascular Events in Patients with Heart Failure
por: Fukuda, Hiroki, et al.
Publicado: (2018)

Triglyceride-Glucose Index and Cardiovascular Events in Kidney Transplant Recipients
por: Colladant, Mathilde, et al.
Publicado: (2023)

Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease
por: Baksh, Sheriza N., et al.
Publicado: (2020)

Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China
por: Jiang, Minghuan, et al.
Publicado: (2019)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events
por: Versteylen, M. O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kf7ljvvmbsius8mes9j8qkahu5